Proteomics can improve breast cancer treatmen

In In The News by Barbara Jacoby

From medicalxpress.com Researchers at Karolinska Institutet in Sweden have identified a protein that could help physicians decide what type of therapy patients with hormone driven breast cancer should go through. In a study, published in Nature Communications, they show that high levels of a protein called retinoic acid receptor alpha (RARA) in breast tumors can be linked to an insufficient …

Risk Of Breast Cancer Recurrence After Tamoxifen Treatment Predicted By Biomarker

In In The News by Barbara Jacoby

From Medical News Today A biomarker reflecting expression levels of two genes in tumor tissue may be able to predict which women treated for estrogen-receptor (ER)-positive breast cancer should receive a second estrogen-blocking medication after completing tamoxifen treatment. In their report published online in the Journal of the National Cancer Institute, Massachusetts General Hospital (MGH) Cancer Center investigators describe finding …